Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294564 · ClinicalTrials.gov registry record · Early Phase 1
Cognitive, Emotional, and Neural Responses to Acute Inflammation
A Early Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
NCT03294564: Completed Early Phase 1 study, sponsored by University of California, San Francisco.
NCT03294564 is a Early Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 24 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03294564, a Early Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is a pilot study to examine the effects of acute inflammation on cognition and emotion in healthy participants using a between-subjects, randomized, double-blind design.
Primary Outcome
Participants will receive a vaccine or placebo and investigators will examine inflammation levels during three different time points via blood draws
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Typhoid Vi Polysaccharide Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2018-12-30 |
| Phase | Early Phase 1 |
What the finished NCT03294564 record still lists
NCT03294564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03294564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03294564 about?
NCT03294564 is a clinical study titled "Cognitive, Emotional, and Neural Responses to Acute Inflammation". This study is a pilot study to examine the effects of acute inflammation on cognition and emotion in healthy participants using a between-subjects, randomized, double-blind design.
What is the current status of trial NCT03294564?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2018-01-01. Estimated completion is 2018-12-30.
What interventions are being tested in trial NCT03294564?
The interventions under investigation include: Placebo (BIOLOGICAL), Typhoid Vi Polysaccharide Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT03294564?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03294564's enrollment target sits among peer trials
24 1037th of 2000 higher than 914 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI